World No 2 Iga Swiatek has accepted a one-month suspension after testing positive for a banned substance, the International Tennis Integrity Agency (ITIA) announced on Thursday.
Swiatek, 23, tested positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024 when the Polish player was ranked No 1 in the world.
The ITIA, however, accepted that it was caused by “the contamination of a regulated non-prescription medication (melatonin), manufactured and sold in Poland that the player had been taking for jet lag and sleep issues”.
SPONSOR AD
“I’m finally allowed… so I instantly want to share with you something that became the worst experience of my life,” an emotional Swiatek said in a post on social media.